在肺癌中微RNA的研究进展
Wenqing Long1, Lulin Cheng1, Yifan Shang1
1Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Discover oncology
|January 29, 2026
概括
微RNAs (miRNAs) 是肺癌 (LC) 发展和进展的关键调节者. 本综述强调了它们在非小细胞肺癌 (NSCLC) 管理中的诊断,预后和治疗潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 肺癌 (LC) 是癌症死亡的主要原因,非小细胞肺癌 (NSCLC) 占大多数病例.
- 尽管有治疗方面的进步,但药物耐药性和转移等挑战仍然存在,限制了生存改善.
- 不调节的微RNA (miRNA) 表达越来越被认为是LC启动和进展的关键因素.
研究的目的:
- 审查目前对肺癌 (LC) 中的微RNA (miRNA) 的理解.
- 要强调分类,信号通路相互作用和LC中的miRNAs的临床翻译潜力.
- 探索miRNAs在LC诊断,预后和治疗预测中的应用.
主要方法:
- 关于肺癌中miRNAs最近研究的文献综述.
- 分析miRNA分类及其在细胞过程中的作用.
- 检查miRNA参与与LC相关的关键信号通路的研究.
- 评估miRNAs用于临床应用的翻译潜力.
主要成果:
- 微RNA (miRNA) 是小型非编码RNA,对基因调节至关重要,影响基因增殖,新陈代谢,应激反应和亡.
- 异常miRNA表达与肺癌 (LC) 的启动,进展和治疗反应密切相关.
- miRNAs显示出作为早期检测,预后和预测NSCLC治疗结果的生物标志物的巨大潜力.
结论:
- 微RNAs (miRNAs) 在肺癌 (LC) 中发挥着多方面的作用,影响瘤生长,转移和对治疗的反应.
- 调节miRNA表达是一种有前途的治疗策略,用于肺癌 (LC) 治疗.
- 在非小细胞肺癌 (NSCLC) 中,miRNAs对改善早期诊断,预后和个性化治疗策略具有重大承诺.
相关概念视频
MicroRNAs
24.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs
4.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
mTOR Signaling and Cancer Progression
4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.8K
Lung Capacity
56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Pleura of the Lungs
7.2K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
7.2K


